Effectiveness and Safety of Anlotinib with or without S-1 in the Treatment of Patients with Advanced Hepatocellular Carcinoma in Chinese Population: A Prospective, Phase 2 Study. Radiology and Oncology, v. 57, n. 3, p. 405–410, 11 Sep.2023.